# Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques

> **NCT04334811** · NA · WITHDRAWN · sponsor: **University of Texas Southwestern Medical Center**

## Conditions studied

- Tachycardia, Ventricular

## Interventions

- **RADIATION:** Stereotactic ablative radiotherapy

## Key facts

- **NCT ID:** NCT04334811
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-02
- **Primary completion:** 2025-03-01
- **Final completion:** 2025-03-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study was stopped due to participation in a multi-center randomized controlled trial with competing enrollment criteria.
- **Last updated:** 2022-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04334811

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04334811, "Stereotactic Ablative Radiotherapy (SAbR) for Treatment of Ventricular Tachycardia (VT) Refractory Standard Invasive Ablation Techniques". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04334811. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*